PMID: 9443604Jan 27, 1998Paper

Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts

Biochimica Et Biophysica Acta
M ShitashigeS Murota

Abstract

Recent studies suggested that prostaglandin endoperoxide H synthase- and prostaglandin endoperoxide H synthase-2 (PGHS-1 and PGHS-2) utilize different pools of arachidonic acid for synthesizing prostanoids. Using cultured murine NIH3T3 fibroblasts, we investigated the mechanism for the different utilization of arachidonic acid between PGHS-1 and -2. Histofluorescence staining for PGHS activity in intact cells demonstrated that quiescent 3T3 cells expressed only PGHS-1 activity and serum-activated 3T3 cells pretreated with aspirin expressed only PGHS-2 activity. Endogenous arachidonic acid released by calcium ionophore A23187 was not converted by PGHS-1 but exclusively converted by PGHS-2. In the cell free system, the kinetics of PGHS-1 were not so much different from those of PGHS-2. However, in intact cells, arachidonic acid at concentrations lower than 2.5 microM was converted by PGHS-2 alone but not by PGHS-1. Our findings indicated that this small amount of arachidonic acid as released by some stimuli is converted exclusively by PGHS-2. Furthermore, treating the PGHS-2-expressing cells with sodium selenite or ebselen, reducing agents of intracellular peroxides, only decreased PGHS-2 activity. We speculate that only PGHS-2 h...Continue Reading

References

May 25, 1977·Biochimica Et Biophysica Acta·F J Van der OuderaaD A Van Dorp
Apr 1, 1976·Biochemical Medicine·K Yagi
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T Hla, K Neilson
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K O'BanionD A Young
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L L LinJ L Knopf
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·W L XieD L Simmons
Apr 24, 1991·Biochimica Et Biophysica Acta·W L Smith, L J Marnett
May 8, 1991·Biochimica Et Biophysica Acta·D L DeWitt
Jun 13, 1991·The New England Journal of Medicine·P M Brooks, R O Day
Jan 1, 1988·Toxicology and Applied Pharmacology·N S ParmarA M Ageel
Jan 1, 1986·Annual Review of Biochemistry·P NeedlemanJ B Lefkowith
May 5, 1995·The Journal of Biological Chemistry·I MoritaW L Smith
Dec 1, 1993·Archives of Biochemistry and Biophysics·L FengD Hwang
Mar 1, 1993·Free Radical Biology & Medicine·H Sies
Jul 16, 2008·Journal of Materials Science. Materials in Medicine·X G ZhangC X Li
Oct 7, 2008·The Journal of Physical Chemistry. a·J BañuelosI López Arbeloa

❮ Previous
Next ❯

Citations

Apr 28, 2004·Molecular and Cellular Endocrinology·P VernetJ R Drevet
Oct 21, 2000·European Journal of Pharmacology·I Wakabayashi, K Yasui
Jan 16, 2002·Prostaglandins & Other Lipid Mediators·Ichiro WakabayashiMunetaka Negoro
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Ikuo Morita
Jan 11, 2003·Free Radical Biology & Medicine·Hirotaka Imai, Yasuhito Nakagawa
Aug 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y NakanishiM Nagumo
Sep 29, 2011·Chemical Reviews·William L SmithPer-Johan Jakobsson
Jun 20, 2001·The Journal of Clinical Investigation·W L Smith, R Langenbach
Apr 12, 2014·Prostaglandins & Other Lipid Mediators·Michiko KawamuraYoshiteru Harada
Aug 4, 1998·FEBS Letters·R J Kulmacz
Dec 25, 2007·Trends in Biochemical Sciences·William L Smith
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Alessandro FedericoCarmela Loguercio
Mar 17, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jean Y ParkSteven B Abramson
Sep 6, 2005·Biochemical and Biophysical Research Communications·Noriko UenoMakoto Murakami
Aug 31, 2000·Annual Review of Biochemistry·W L SmithR M Garavito
Apr 28, 2007·The Journal of Biological Chemistry·Jiayan LiuWilliam L Smith
Sep 18, 2002·Japanese Journal of Pharmacology·Tadashi NagamatsuYoshio Suzuki
Jan 17, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Nobuhito TanakaIkuo Morita
Jun 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wen LiuRichard J Kulmacz
Oct 8, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chiara BolegoAngelo Sala
Mar 3, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Jin Cheng YaoLu Yong Zhang
Dec 31, 2014·The Journal of Biological Chemistry·Chong Yuan, William L Smith
Nov 29, 2017·Journal of Lipid Research·Xinzhi LiColin D Funk
Jun 22, 2001·The Journal of Biological Chemistry·N UenoI Kudo
Dec 17, 2004·Alternatives to Laboratory Animals : ATLA·Michael Braun, Manfred Kietzmann
Nov 20, 2003·The Journal of Biological Chemistry·Bijan BambaiRichard J Kulmacz
Nov 18, 2006·The Journal of Biological Chemistry·Ying YuColin D Funk
Feb 4, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yukihiro YagiHirokazu Tsubone
May 1, 2021·Animals : an Open Access Journal From MDPI·Sven BudikChristine Aurich
Jun 20, 2003·Progress in Lipid Research·Richard J KulmaczAh-Lim Tsai
Jul 20, 2021·Pharmacology Research & Perspectives·Christopher J EshLee Taylor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.